---
figid: PMC10380453__ijms-24-11403-g001
pmcid: PMC10380453
image_filename: ijms-24-11403-g001.jpg
figure_link: /pmc/articles/PMC10380453/figure/ijms-24-11403-f001/
number: Figure 1
figure_title: ''
caption: 'HER2 signaling pathway and binding union site of antibodies targeting HER2.
  HER2 receptor contains four extracellular domains: I, II, III and IV, as represented.
  Each HER2-directed therapy to a specific domain of the receptor.'
article_title: 'HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel
  Therapeutic Strategies.'
citation: Anna Pous, et al. Int J Mol Sci. 2023 Jul;24(14):11403.
year: '2023'

doi: 10.3390/ijms241411403
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- gastric cancer
- HER2
- immunotherapy
- PD-1/PD-L1
- antibody-drug conjugate
- chemotherapy
- trastuzumab
- novel therapies
- clinical trials

---
